Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06892 | 32707340 | Clin Gastroenterol Hepatol | Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. | 2020 | Details |
| A06895 | 32706931 | Liver Int | Factors independently associated with cardiorespiratory fitness in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06918 | 32698063 | Int J Biol Macromol | Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota. | 2020 | Details |
| A06924 | 32696189 | Metab Brain Dis | Melatonin regulates neurodegenerative complications associated with NAFLD via enhanced neurotransmission and cellular integrity: a correlational study. | 2020 | Details |
| A06925 | 32696080 | Clin Res Cardiol | NAFLD and cardiovascular diseases: a clinical review. | 2020 | Details |
| A06938 | 32692879 | Mol Nutr Food Res | Inflammatory Diseases and Vitamin E-What Do We Know and Where Do We Go? | 2020 | Details |
| A06959 | 32686456 | Rev Esp Enferm Dig | What may GLP1 receptor agonists contribute to the treatment of patients with non-alcoholic fatty liver disease? | 2020 | Details |
| A06964 | 32684985 | Diabetol Metab Syndr | NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. | 2020 | Details |
| A06970 | 32683103 | Clin Gastroenterol Hepatol | Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06971 | 32683094 | Ann Hepatol | Cerebral hemodynamics in the non-alcoholic fatty liver. | 2020 | Details |
| A06977 | 32679195 | Arch Biochem Biophys | (-)-Epicatechin and the comorbidities of obesity. | 2020 | Details |
| A06979 | 32677717 | Diabetes Metab Res Rev | NAFLD in type 2 diabetes mellitus: Still many challenging questions. | 2020 | Details |
| A06980 | 32677680 | Clin Sci (Lond) | Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis. | 2020 | Details |
| A06990 | 32670822 | J Tradit Complement Med | The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease. | 2020 | Details |
| A06997 | 32666779 | Pol Arch Intern Med | Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice. | 2020 | Details |
| A07001 | 32664383 | Antioxidants (Basel) | The Interplay between Oxidative Stress and miRNAs in Obesity-Associated Hepatic and Vascular Complications. | 2020 | Details |
| A07025 | 32654390 | Liver Int | The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study. | 2020 | Details |
| A07027 | 32652824 | Liver Int | NAFLD is related to Post-prandial Triglyceride-enrichment of HDL Particles in Association with Endothelial and HDL Dysfunction. | 2020 | Details |
| A07048 | 32643194 | Prenat Diagn | Perinatal exposure to maternal obesity: Lasting cardiometabolic impact on offspring. | 2020 | Details |
| A07052 | 32640331 | Food Chem Toxicol | Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. | 2020 | Details |
| A07060 | 32638417 | Aliment Pharmacol Ther | Review article: the impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitis. | 2020 | Details |
| A07063 | 32636124 | Nutr Metab Cardiovasc Dis | Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD. | 2020 | Details |
| A07069 | 32633873 | J Intern Med | Nonalcoholic fatty liver disease is associated with a decreased myocardial mechano-energetic efficiency. | 2020 | Details |
| A07071 | 32632387 | Transl Gastroenterol Hepatol | Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation. | 2020 | Details |
| A07084 | 32629123 | Clin Gastroenterol Hepatol | Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases. | 2020 | Details |
| A07090 | 32626832 | Hepatol Commun | Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis-4 Score. | 2020 | Details |
| A07093 | 32626560 | Middle East J Dig Dis | Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events. | 2020 | Details |
| A07099 | 32622843 | Metabolism | Defects in High Density Lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of Hepatocyte Nuclear Factor 4A. | 2020 | Details |
| A07111 | 32619031 | Diabet Med | Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. | 2020 | Details |
| A07126 | 32612827 | SAGE Open Med | Nonalcoholic fatty liver disease and cardiovascular disease phenotypes. | 2020 | Details |
| A07133 | 32607888 | Methods Mol Biol | In Vivo Investigation of High-Fat Diet-Induced Hepatic Lipid Dysfunctions. | 2020 | Details |
| A07143 | 32603950 | Atherosclerosis | Impact of lifestyle and cardiovascular risk factors on early atherosclerosis in a large cohort of healthy adolescents: The Early Vascular Ageing (EVA)-Tyrol Study. | 2020 | Details |
| A07149 | 32599713 | Int J Mol Sci | Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age. | 2020 | Details |
| A07165 | 32595023 | Obes Res Clin Pract | Pro-inflammatory HDL in women with obesity and nonalcoholic steatohepatitis. | 2020 | Details |
| A07187 | 32589269 | Eur J Clin Invest | Genetic predisposition in metabolic-dysfunction-associated fatty liver disease and cardiovascular outcomes-Systematic review. | 2020 | Details |
| A07188 | 32589264 | Eur J Clin Invest | COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics. | 2020 | Details |
| A07195 | 32586479 | Clin Geriatr Med | Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes. | 2020 | Details |
| A07244 | 32569680 | Metabolism | Metabolic liver disease in diabetes - From mechanisms to clinical trials. | 2020 | Details |
| A07247 | 32568734 | J Pediatr Endocrinol Metab | Definition and early diagnosis of metabolic syndrome in children. | 2020 | Details |
| A07259 | 32563249 | Lipids Health Dis | Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study. | 2020 | Details |
| A07276 | 32558189 | Liver Int | The risk of pregnancy-associated hypertension in women with nonalcoholic fatty liver disease. | 2020 | Details |
| A07299 | 32550751 | World J Gastroenterol | Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management. | 2020 | Details |
| A07319 | 32540736 | Diabetes Metab Syndr | Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19. | 2020 | Details |
| A07323 | 32537840 | Hepatol Res | Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: Data from Hong Kong. | 2020 | Details |
| A07330 | 32534588 | Cardiovasc Diabetol | Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study. | 2020 | Details |
| A07331 | 32534575 | Cardiovasc Diabetol | Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity. | 2020 | Details |
| A07340 | 32531370 | Int J Biol Macromol | The protective effects of walnut green husk polysaccharide on liver injury, vascular endothelial dysfunction and disorder of gut microbiota in high fructose-induced mice. | 2020 | Details |
| A07342 | 32531295 | Metabolism | Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. | 2020 | Details |
| A07355 | 32526850 | Molecules | The Potential Therapeutic Value of Medicinal Plants in the Management of Metabolic Disorders. | 2020 | Details |
| A07368 | 32524096 | Hawaii J Health Soc Welf | Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i. | 2020 | Details |
| A07371 | 32523319 | World J Gastroenterol | Association between non-alcoholic fatty liver disease and obstructive sleep apnea. | 2020 | Details |
| A07382 | 32519009 | Curr Diab Rep | Purine Metabolite Signatures and Type 2 Diabetes: Innocent Bystanders or Actionable Items? | 2020 | Details |
| A07401 | 32514450 | JGH Open | Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes. | 2019 | Details |
| A07407 | 32512752 | Nutrients | The Effect of Three Mediterranean Diets on Remnant Cholesterol and Non-Alcoholic Fatty Liver Disease: A Secondary Analysis. | 2020 | Details |
| A07411 | 32510837 | Liver Int | Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity. | 2020 | Details |
| A07416 | 32508312 | Eur J Endocrinol | Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease. | 2020 | Details |
| A07419 | 32507551 | Ann Hepatol | Prevalence of NAFLD in Guatemala following exposure to a protein-energy nutrition intervention in early life. | 2020 | Details |
| A07439 | 32496342 | Am J Gastroenterol | Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality. | 2020 | Details |
| A07444 | 32494263 | Pak J Med Sci | Fatty liver in Pakistani cohort with rheumatoid arthritis. | 2022 | Details |
| A07481 | 32477116 | Front Pharmacol | Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application. | 2020 | Details |
| A07484 | 32476802 | World J Gastroenterol | Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative. | 2020 | Details |
| A07490 | 32475980 | Med Sci Monit | Analysis of Risk Factors for Adverse Cardiovascular Events in Elderly Patients with Acute Myocardial Infarction and Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A07494 | 32475354 | Lipids Health Dis | Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis. | 2020 | Details |
| A07506 | 32467498 | Am J Ther | How to Reduce Cardiovascular Risk in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07522 | 32460140 | Atherosclerosis | Hepatocyte-like cells derived from induced pluripotent stem cells: A versatile tool to understand lipid disorders. | 2020 | Details |
| A07534 | 32453041 | Am J Gastroenterol | Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07542 | 32450149 | Gastroenterology | Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122. | 2020 | Details |
| A07566 | 32440840 | J Nephrol | Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease. | 2020 | Details |
| A07571 | 32440372 | PeerJ | Nonalcoholic fatty liver disease, a potential risk factor of non-specific ST-T segment changes: data from a cross-sectional study. | 2020 | Details |
| A07582 | 32436128 | High Blood Press Cardiovasc Prev | Evaluation of Cardiovascular Risk in Patient with Primary Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A07584 | 32435522 | World J Gastrointest Pathophysiol | Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics. | 2020 | Details |
| A07591 | 32432142 | World J Clin Cases | Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature. | 2020 | Details |
| A07595 | 32431115 | Diabetes Metab J | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. | 2020 | Details |
| A07601 | 32429274 | Nutrients | The Protective Effect of Cynara Cardunculus Extract in Diet-Induced NAFLD: Involvement of OCTN1 and OCTN2 Transporter Subfamily. | 2020 | Details |
| A07615 | 32420328 | Biomed Res Int | Prevalence of Metabolic Syndrome and Nonalcoholic Fatty Liver Disease among Premenopausal and Postmenopausal Women in Ho Municipality: A Cross-Sectional Study. | 2020 | Details |
| A07636 | 32413340 | Lancet Gastroenterol Hepatol | Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2020 | Details |
| A07648 | 32409850 | Internist (Berl) | [New pharmacological treatment options for nonalcoholic fatty liver disease]. | 2020 | Details |
| A07657 | 32407146 | Arch Physiol Biochem | trans-Chalcone inhibits transforming growth factor-β1 and connective tissue growth factor-dependent collagen expression in the heart of high-fat diet-fed rats. | 2020 | Details |
| A07660 | 32405182 | J Clin Exp Hepatol | Natural History of Simple Steatosis or Nonalcoholic Fatty Liver. | 2019 | Details |
| A07687 | 32390698 | World J Gastroenterol | Macrophages in metabolic associated fatty liver disease. | 2020 | Details |
| A07700 | 32387227 | Metabolism | Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. | 2020 | Details |
| A07704 | 32384593 | Nutrients | Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD. | 2020 | Details |
| A07715 | 32378295 | Liver Int | Mesenchymal iron deposition is associated with adverse long-term outcome in non-alcoholic fatty liver disease. | 2020 | Details |
| A07732 | 32372515 | Aliment Pharmacol Ther | Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. | 2020 | Details |
| A07744 | 32367624 | Pediatr Obes | Increased atherogenic lipoprotein profile in children with non-alcoholic steatohepatitis. | 2020 | Details |
| A07765 | 32360822 | Clin Gastroenterol Hepatol | PNPLA3 Gene Polymorphism and Liver- and Extrahepatic Cancer-Related Mortality in the United States. | 2020 | Details |
| A07773 | 32359737 | Clin Nutr ESPEN | Effects of the Mediterranean diet on cardiovascular risk factors in non-alcoholic fatty liver disease patients: A systematic review and meta-analysis. | 2020 | Details |
| A07775 | 32359355 | Cardiovasc Diabetol | Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study. | 2020 | Details |
| A07779 | 32356922 | Diabetes Metab Res Rev | Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance. | 2020 | Details |
| A07789 | 32354182 | J Clin Med | Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research. | 2020 | Details |
| A07809 | 32349939 | Ann Hepatol | Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. | 2020 | Details |
| A07821 | 32345225 | BMC Cardiovasc Disord | Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a nationwide population-based study in Korea. | 2020 | Details |
| A07839 | 32338202 | Curr Med Chem | Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review. | 2021 | Details |
| A07843 | 32337295 | J Diabetes Res | Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders. | 2020 | Details |
| A07859 | 32331389 | Cells | The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review. | 2020 | Details |
| A07889 | 32321858 | Gut | NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. | 2020 | Details |
| A07896 | 32318489 | J Family Med Prim Care | Determination of association between nonalcoholic fatty liver disease and carotid artery atherosclerosis among nondiabetic individuals. | 2020 | Details |
| A07897 | 32317862 | Mediators Inflamm | Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome. | 2020 | Details |
| A07900 | 32317584 | Eur J Gastroenterol Hepatol | De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors. | 2021 | Details |
| A07910 | 32314167 | Indian J Gastroenterol | Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity. | 2020 | Details |